Clinical Trial Update: Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder

View source ↗

Summary

An observational study evaluating botulinum toxin type A for urinary incontinence due to overactive bladder (including neurogenic bladder) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Bladder
• Overactive Bladder

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Urinary Bladder, Overactive, Urinary Bladder, Neurogenic | Status: COMPLETED